Esperion Therapeutics Inc (NASDAQ:ESPR) - Share price - Overview

Stock Report

Esperion Therapeutics Inc ESPR

Last Price
$32.83

Day Change
-0.45|-1.35%

As of 26/05/2017
17:30:11 EDT | USD
Minimum 15 Minutes Delay.

Last Close33.28
Day Range32.54 - 34.42
Mkt Cap741.60Mil
52-Wk Range9.40 - 48.21
Yield %-
ISINUS29664W1053
Volume397,831
P/E-7.33
P/S-
P/CF-10.25

Share Price

Financials
201420152016
More ...
Income Statement
Revenue0.000.00-
Operating Income-36.22-50.04-76.15
Net Income-36.38-49.78-74.98
Basic EPS-2.22-2.26-3.33
Avg. Diluted Shares Outstanding162223
Balance Sheet
Current Assets106.77214.39213.58
Non Current Assets36.5881.1831.64
Total Assets143.34295.57245.21
Current Liabilities5.495.6315.59
Total Liabilities9.798.3116.61
Total Equity133.55287.26228.60
Cash Flow
Operating Cash Flow-32.02-38.16-47.73
Capital Expenditure-0.87-0.33-0.09
Free Cash Flow-32.89-38.48-47.82

In millions, except "Basic EPS". Currency is USD.

Company Profile

Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

44
Key Stats
More ...
Price/Earning TTM-7.43
Price/Book3.91
Price/Sales TTMInfinity
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-
Net Margin % TTM-
ROE TTM-29.07
Debt/Equity0.00
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.